Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($) series compound segment	Dec. 31, 2017	Oct. 01, 2019 USD ($)	Jan. 01, 2019 USD ($)
Accounting Policies [Line Items]
Number of series of selective cortisol modulators | series	4
Number of compounds (more than) | compound	500
Number of operating segments | segment	1
Operating lease right-of-use asset	$ 3,446
Total lease liability	$ 3,461
Sales Revenue, Net | Customer Concentration Risk
Accounting Policies [Line Items]
Percentage of sales to one specialty distributor, less than	1.00%	1.00%
Accounting Standards Update 2016-02
Accounting Policies [Line Items]
Operating lease right-of-use asset				$ 1,900
Total lease liability			$ 3,000	1,900
Minimum | Accounting Standards Update 2016-02
Accounting Policies [Line Items]
Operating lease right-of-use asset				1,900
Total lease liability				1,500
Maximum | Accounting Standards Update 2016-02
Accounting Policies [Line Items]
Total lease liability				$ 2,500